Holen Sie sich die Stockscreener-App
39.76
4.30%
1.64
Schlusskurs vom Vortag:
$38.12
Offen:
$38.12
24-Stunden-Volumen:
2.59M
Relative Volume:
1.08
Marktkapitalisierung:
$6.04B
Einnahmen:
$3.44B
Nettoeinkommen (Verlust:
$75.20M
KGV:
75.89
EPS:
0.5239
Netto-Cashflow:
$49.30M
1W Leistung:
-6.29%
1M Leistung:
-17.83%
6M Leistung:
+16.12%
1J Leistung:
-21.66%
1-Tages-Spanne:
$37.99
$40.04
1-Wochen-Bereich:
$35.62
$40.48
52-Wochen-Spanne:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
39.76 | 5.79B | 3.44B | 75.20M | 49.30M | 0.5239 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Don't Overlook Bruker (BRKR) International Revenue Trends While Assessing the Stock - Yahoo Finance
Bruker Corp (BRKR) Shares Up 3.12% on Feb 17 - GuruFocus
Bruker's Q4 Earnings Lag Estimates, Margins Contract, Stock Down - Yahoo Finance
US$48.43: That's What Analysts Think Bruker Corporation (NASDAQ:BRKR) Is Worth After Its Latest Results - 富途牛牛
These analysts cut their forecasts on Bruker following Q4 results - MSN
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $35 to $49 - 富途牛牛
Can Bruker Corporation expand into new marketsPortfolio Gains Summary & Stepwise Trade Execution Plans - mfd.ru
A Look At Bruker (BRKR) Valuation After Mixed Earnings And Soft 2026 Growth Outlook - Yahoo Finance
Forecasting The Future: 15 Analyst Projections For Bruker - Benzinga
Bruker (BRKR) Price Target Lowered by Citigroup, Rating Maintained | BRKR Stock News - GuruFocus
These Analysts Cut Their Forecasts On Bruker Following Q4 Results - Benzinga
Bruker (BRKR) Target Price Adjustment: Barclays Lowers Price Tar - GuruFocus
Bruker (BRKR) Is Down 8.6% After Mixed 2025 Results and Cautious 2026 Guidance Has The Bull Case Changed? - Yahoo Finance
Bruker Corporation (NASDAQ:BRKR) Q4 2025 Earnings Call Transcript - Insider Monkey
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $40 to $53 - 富途牛牛
Earnings call transcript: Bruker Q4 2025 earnings miss, stock drops 14% By Investing.com - Investing.com South Africa
Bruker Shares Tumble on Q4 Earnings Miss and Weaker Margins Despite 2026 Growth Outlook - AlphaStreet News
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $50 - 富途牛牛
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... - Yahoo Finance
Bruker (NASDAQ:BRKR) Announces Earnings Results - MarketBeat
Why Bruker (BRKR) Stock Is Trading Lower Today - Finviz
Bruker Q4 2025 slides reveal organic decline, stock drops 14% despite FY 2026 optimism - Investing.com
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Earnings call transcript: Bruker Q4 2025 earnings miss, stock drops 14% - Investing.com
Bruker: Q4 Financial Results Overview - Bitget
Bruker: Q4 Earnings Snapshot - KVUE
Bruker (BRKR) Q4 Earnings Miss Estimates - Yahoo Finance
Bruker’s (NASDAQ:BRKR) Q4 CY2025 Sales Beat Estimates - Yahoo Finance
BRUKER ($BRKR) Releases Q4 2025 Earnings - Quiver Quantitative
Bruker earnings missed by $0.06, revenue topped estimates - Investing.com
Bruker earnings missed by $0.06, revenue topped estimates By Investing.com - Investing.com South Africa
Bruker Corporation Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView
Bruker Earnings Review: Q4 Summary - Benzinga
Bruker Reports Fourth Quarter and Full Year 2025 Financial Results - ChartMill
Bruker Corp (BRKR) Q4 2025 Earnings Call Highlights: Navigating Challenges and Setting the ... By GuruFocus - Investing.com Canada
Bruker earnings up next: Can momentum continue after Q3 beat? - Investing.com
Bruker earnings up next: Can momentum continue after Q3 beat? By Investing.com - Investing.com South Africa
A Glimpse of Bruker's Earnings Potential - Benzinga
Candriam S.C.A. Cuts Stock Position in Bruker Corporation $BRKR - MarketBeat
Bruker Introduces Label-Free Characterization Platform for Nanoscale Bioparticles - Contract Pharma
Bruker Corporation Announces the Launch of iNTApharma - marketscreener.com
Bruker (BRKR) Launches iNTApharma for Advanced Bioparticle Analy - GuruFocus
Bruker Introduces iNTApharma™, a Label‑Free Platform for Nanoparticle Characterization in mRNA Drug and Gene Therapy Development and QC - ChartMill
Bruker Announces Quarterly Preferred Stock Dividend - 富途牛牛
Old West Investment Management LLC Buys 338,618 Shares of Bruker Corporation $BRKR - MarketBeat
Shareholders in Bruker (NASDAQ:BRKR) have lost 43%, as stock drops 7.2% this past week - Yahoo Finance
Analysts Estimate Bruker (BRKR) to Report a Decline in Earnings: What to Look Out for - Finviz
Bruker Announces Date and Time of Fourth Quarter 2025 Earnings Release and Webcast - marketscreener.com
Bruker (BRKR) to Release Quarterly Earnings on Thursday - MarketBeat
New York State Common Retirement Fund Has $12.05 Million Stake in Bruker Corporation $BRKR - MarketBeat
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $55 - 富途牛牛
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):